Home » Newsletters » BioWorld Science

BioWorld Science

May 6, 1997

View Archived Issues

Pfizer's CP-148623 lowers serum cholesterol in humans

Results from analysis of 10 years of amiodarone therapy presented

Sanofi claims HLE inhibitors

Pharma Mar isolates new cytotoxic agents from marine sponge

Squalene synthase inhibitors reported by Takeda

AMPA/NMDA receptor antagonists from Rhone-Poulenc Rorer

Kaneka discloses anti-H. pylori rifamycins

Prokinetic agents from Kyorin

Cyclic hexapeptide antitumor agents described by Taisho

Daiichi and Fuji prepare new analgesics

Gilead's cidofovir injection approved in the European Union

OraVax: Q1 1997 highlights

Biosource Technologies awarded NIH grant to develop melanin as an antiinflammatory compound

Neurotrophic factor gene therapy shows promise for motor neuron diseases

Chiron and DepoTech complete NDA for DepoCyt

AGM-1470 may have potential for controlling fertility

Progress report on Cypros's adenosine and neuronal calcium channel preclinical programs

ABT-431 evaluated in Parkinson's patients

Hybridon and the Institute of Human Virology enter antisense AIDS therapy collaboration

SIBIA identifies biochemical marker for Alzheimer's disease

Clinical efficacy of Myotrophin in ALS and postpolio syndrome

Salix to commence clinical trials with Normix

Rhone-Poulenc Rorer licenses Granocyte for additional countries

Cytel and Schwarz terminate research collaboration

Neuromyalgic response to rhNGF described

Helix BioPharma enters research and development agreement

FDA grants SciClone orphan drug status for CPX

FDA clears generic version of SKB's Compazine

Transdermal N-0923 effective in Parkinson's disease

COX-2 inhibitor shows potential for preventing neuronal death

Preclinical studies with sodium channel blockers in traumatic brain injury

BioCryst commences phase I trial of HIV compound

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.